Biotech Analyst Tsai, along with Key Opinion Leader, Dr. Amy Chi, discuss Ligand Pharmaceuticals’ partner, Verona Pharma’s, Ohtuvayre, a new inhaled treatment for Chronic Obstructive Pulmonary Disease (COPD) on an Analyst/Industry conference call to be held on September 12 at 1 pm. Webcast Link
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGND: